These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 733081)

  • 21. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
    Calabrese L; Zoni R
    Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of gamma irradiation and radioprotector MPG on liver glycogen in mice.
    Khan AS; Bhartiya HC; Bhartiya KM
    Radiobiol Radiother (Berl); 1986; 27(4):473-7. PubMed ID: 3775007
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
    De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
    Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of MPG (2-mercapto-propionyl-glycine) in atrophic enteritis and aregenerative enteropathies.
    Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
    Panminerva Med; 1977; 19(4):227-35. PubMed ID: 593700
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.
    Hoppe A; Denneberg T; Kågedal B
    Am J Vet Res; 1988 Jun; 49(6):923-8. PubMed ID: 3400930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protective activity of tiopronin in relation to the acute exacerbation of chronic bronchitis].
    Straneo G; Avanzini F; Scaglione F; Coppi G; Fraschini F
    Clin Ter; 1987 Mar; 120(6):503-10. PubMed ID: 2954743
    [No Abstract]   [Full Text] [Related]  

  • 30. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some aspects of "deep lung" cellular immunity in chronic bronchitis before and after therapy with tiopronin.
    Fraschini F; Scaglione F; Coppi G; Piazza G; Marchi E; Montoli CC; Scarpazza G
    Int J Clin Pharmacol Res; 1987; 7(2):129-33. PubMed ID: 3495498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioprotection to mice by combination of hydroxytryptophan with AET or MPG: bone marrow histology study.
    Ghose A; Ganguly SU; Kaur J; Mathur M
    Radiobiol Radiother (Berl); 1987; 28(4):477-82. PubMed ID: 3500482
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acadione, a new long-term treatment of rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A
    Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):462-6. PubMed ID: 3393845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
    Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
    Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The free bilirubin tolerance test as a liver function test and its comparison with the BSF tolerance test].
    Gentilini P; Surrenti C; Candidi Tommasi A; Camilloni R
    Sperimentale; 1969; 119(4):281-97. PubMed ID: 5402934
    [No Abstract]   [Full Text] [Related]  

  • 37. [Histological and ultramicroscopic aspects of the small intestine in aregenerative enteropathies after treatment with 2-mercapto-propionyl-glycine (Thiola)].
    Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
    Minerva Med; 1977 Jul; 68(36):2491-8. PubMed ID: 887228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.